Abbott Labs, St. Jude Lurch On Muddy Waters Tussle Despite Q3 Sales Beats

St. Jude Medical (STJ) stock dipped a fraction early Wednesday after the medical device-maker reported Q3 earnings that narrowly missed views amid an ongoing security tussle with short-seller Muddy Waters.

Meanwhile, shares of Abbott Laboratories (ABT) -- which is in the process of acquiring St. Jude — toppled despite a breezy Q3 beat. Quarterly growth in medical device sales more than offset a decline in Abbott's nutrition unit.

IBD'S TAKE: Medical stocks are suffering amid a volatile...

What feeling does this article give you?

#hashtags to follow:

STJ [+]    Muddy Waters [+]    Abbott Laboratories [+]    ABT [+]    Abbott [+]    IBD [+]   

More #news: